Comparing multiple measures of glycemia: How to transition from biomarker to diagnostic test?

Clinical Chemistry

Volumn 58, Issue 12, 2012, Pages 1615-1617

  Cohen, Robert M ^a,b   Sacks, David B ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 ANHYDROSORBITOL; ALBUMIN; BIOLOGICAL MARKER; FRUCTOSAMINE; HEMOGLOBIN A1C; URATE OXIDASE;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EDITORIAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; RISK ASSESSMENT;

BLOOD GLUCOSE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE;

EID: 84870346543     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.196139     Document Type: Editorial

References (17)

1. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9.
4. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-91.
5. Koga M, Kasayama S. Clinical impact of glycated albumin as another glycemic control marker. Endocr J 2010;57:751-62.
6. Johnson RN, Metcalf PA, Baker JR. Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 1983;127:87-95.
7. Schleicher ED, Vogt BW. Standardization of serum fructosamine assays. Clin Chem 1990;36:136-9.
8. Dungan KM. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert Rev Mol Diagn 2008;8:9-19.
9. Juraschek SP, Steffes MW, Selvin E. Association of alternative markers of glycemia with hemoglobin A1c and fasting glucose. Clin Chem 2012;58:1648-55.
10. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473-8.
11. Cohen RM, Lindsell CJ. When the blood glucoses and the A1c don't match: turning uncertainty into opportunity [Invited Editorial]. Diabetes Care. Forthcoming 2012.
12. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al., and for the Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2453-7.
13. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, et al. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010;152:770-7.
14. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 2011;154:303-9.
15. Herman WH, Cohen RM. Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 2012;97:1067-72.
16. Sacks DB. A1C versus glucose testing: a comparison. Diabetes Care 2011;34:518-23.
17. Cohen RM, Haggerty S, Herman WH. HbA1c for the diagnosis of diabetes and prediabetes: Is it time for a mid-course correction? J Clin Endocrinol Metab 2010;95:5203-6.